From Casetext: Smarter Legal Research

United States v. Novartis Pharm. Corp.

United States District Court, S.D. New York
Nov 29, 2021
13 Civ. 3700 (KMW) (GWG) (S.D.N.Y. Nov. 29, 2021)

Opinion

13 Civ. 3700 (KMW) (GWG)

11-29-2021

UNITED STATES OF AMERICA; the States of CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, FLORIDA, GEORGIA, HAWAII, ILLINOIS, INDIANA, IOWA, LOUISIANA, MASSACHUSETTS, MICHIGAN, MINNESOTA, MONTANA, NEVADA, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, OKLAHOMA, RHODE ISLAND, TENNESSEE, TEXAS, VIRGINIA, WASHINGTON and WISCONSIN; the DISTRICT OF COLUMBIA, THE CITY OF CHICAGO and THE CITY OF NEW YORK; ex rel ., STEVEN M. CAMBURN, Plaintiffs and Relator, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant.


ORDER EXTENDING TIME TO RESPOND TO THIRD AMENDED COMPLAINT, SETTING A BRIEFING SCHEDULE AND EXTENDING PAGE LIMITS

The Honorable Kimba M. Wood

Upon consideration of the parties' joint request for an extension of time for Defendant's response to the Third Amended Complaint and for a briefing schedule and extension of page limits for any motion to dismiss filed in response to the Third Amended Complaint, it is ORDERED AS FOLLOWS:

The request is GRANTED. Defendant shall respond to the Third Amended Complaint by January 3, 2022. The Court establishes the following briefing schedule and page limits with respect to any motion to dismiss the Third Amended Complaint:

1. Defendant may file a Memorandum of Law in Support of a Motion to Dismiss the Third Amended Complaint that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block);
2. Within thirty (30) days of Defendant's Motion to Dismiss, Plaintiff-Relator may file a Memorandum of Law in Opposition to Defendant's Motion to Dismiss that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block);
3. Within fourteen (14) days of Plaintiff-Relator's opposition, Defendant may file a Memorandum of Law in Reply that shall not exceed twenty (20) pages (excluding the caption, table of contents, table of authorities and signature block).

SO ORDERED 2


Summaries of

United States v. Novartis Pharm. Corp.

United States District Court, S.D. New York
Nov 29, 2021
13 Civ. 3700 (KMW) (GWG) (S.D.N.Y. Nov. 29, 2021)
Case details for

United States v. Novartis Pharm. Corp.

Case Details

Full title:UNITED STATES OF AMERICA; the States of CALIFORNIA, COLORADO, CONNECTICUT…

Court:United States District Court, S.D. New York

Date published: Nov 29, 2021

Citations

13 Civ. 3700 (KMW) (GWG) (S.D.N.Y. Nov. 29, 2021)